NCT03466788View on ClinicalTrials.gov

Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 29, 2018

Primary Completion Date

March 28, 2019

Study Completion Date

March 28, 2019

Conditions

Endometrial CancerChemotherapy EffectQuality of Life

Interventions

OTHER

Self questionnaires of quality of life and living conditions

Patients will complete self-questionnaires of living conditions and quality of life (QLQ-C30; EN24; CIPN20; IPAQ; HADS)

Trial Locations (5)

14076

Centre François Baclesse, Caen

94805

Institut Gustave Roussy, Villejuif

Unknown

Centre Oscar Lambret, Lille

Centre Eugène Marquis, Rennes

Centre Henri Becquerel, Rouen

All Listed Sponsors

lead

Centre Francois Baclesse

OTHER

NCT03466788 - Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer | Biotech Hunter | Biotech Hunter